Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06142019 · ClinicalTrials.gov registry record
Pulse Oximeter Accuracy in Healthy Humans During Hypoxia
A clinical trial of Hypoxia and Skin Pigmentation, sponsored by University of California, San Francisco.
- Recruiting
- Registry status
- 10,000
- Enrollment target
- 1
- Study location
NCT06142019: Recruiting study of Hypoxia and Skin Pigmentation, sponsored by University of California, San Francisco.
NCT06142019 is a study of Hypoxia and Skin Pigmentation that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 10,000 participants, above the 2,860-participant average among 39 other Hypoxia trials with a reported enrollment target (250% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06142019, a study of Hypoxia and Skin Pigmentation, is actively recruiting participants, sponsored by University of California, San Francisco.
- RECRUITING
- Registry status
- 10,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The aim of this project is to test the accuracy of pulse oximeters during mild, moderate and severe hypoxia. This is done by comparing the reading of the pulse oximeter during brief, steady state hypoxia with a gold-standard measurement of blood oxygen. This study will be done on healthy male or females between the age group of 18-50.
Primary Outcome
Reading on pulse oximeter device which is an estimate of the patient's blood oxygen level.
Conditions Studied
Interventions
- DEVICE Controlled desaturation (hypoxemia)
Study Locations (1)
California
- Hypoxia Lab, UCSF Department of Anesthesia and Perioperative Care - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10,000 participants |
| Start Date | 2021-11-29 |
| Est. Completion | 2028-09-01 |
What NCT06142019 shows while recruiting
NCT06142019 is an observational study that tracks outcomes without assigning an intervention. Its 10,000 participants enrollment target places it among the larger protocols in the corpus, above the 2,860-participant average among 39 other Hypoxia trials with a reported enrollment target (250% higher).
The record links to 2 conditions, with Hypoxia appearing as the primary indexed condition, and to 1 intervention - of which Controlled desaturation (hypoxemia) is the first listed.
NCT06142019 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06142019 about?
NCT06142019 is a clinical study titled "Pulse Oximeter Accuracy in Healthy Humans During Hypoxia". The aim of this project is to test the accuracy of pulse oximeters during mild, moderate and severe hypoxia. This is done by comparing the reading of the pulse oximeter during brief, steady state hypoxia with a gold-standard measurement of blood oxygen. This study will be done on healthy male or fem...
What is the current status of trial NCT06142019?
This trial is currently recruiting. The enrollment target is 10,000 participants. The study started on 2021-11-29. Estimated completion is 2028-09-01.
What conditions does trial NCT06142019 study?
This clinical trial studies the following conditions: Hypoxia, Skin Pigmentation.
What interventions are being tested in trial NCT06142019?
The interventions under investigation include: Controlled desaturation (hypoxemia) (DEVICE).
Who is sponsoring clinical trial NCT06142019?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06142019 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypoxia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06142019's enrollment target sits among peer trials
10,000 2nd of 39 the highest of 39 other Hypoxia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hypoxia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Effects of Breathing Training and Nitrate on Exercise at Simulated Altitude
RECRUITING · NA
-
Intravenous Iron Effects on Performance at High Altitude
RECRUITING · Phase 4
-
End-Tidal Oxygen for Intubation in the Emergency Department
RECRUITING · NA
-
Fetal Cerebrovascular Autoregulation in Congenital Heart Disease and Association With Neonatal Neurobehavior
RECRUITING · Phase 2
-
Impact of Early Aging and Menopause on the Vascular Responses to Hypoxia
RECRUITING · Early Phase 1
-
Optimizing Care in Critically Ill at UCHealth by Liberalizing the Target O2 in Mechanically-ventilated ICU Patients
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00160771 · 10,000 participants
Biomechanics/Motion Analysis Laboratory Data Bank
- NCT00896935 · 10,000 participants
Arizona Cancer Center Biospecimen Repository
- NCT00898235 · 10,000 participants
Collection of Samples and Clinical Data From Patients With Amyloid Diseases
- NCT00992303 · 10,000 participants
Collecting Tissue Samples From Patients With Cancer Undergoing Radiation Therapy and Healthy Participants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI